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Abstract. A 22-day-old male was admitted with a 2-day history of irritability, dyspnea, jaundice, fever, and gastroin-
testinal bleeding. A thin blood smear was performed, which showed the presence of intraerythrocyte bacteria identified
as Bartonella bacilliformis, and subsequently, the child was diagnosed with Carrion’s disease. The diagnosis was con-
firmed by specific polymerase chain reaction. The child was born in a non-endemic B. bacilliformis area and had not
traveled to such an area before hospitalization. However, the mother was from an endemic B. bacilliformis area, and
posterior physical examination showed the presence of a wart compatible with B. bacilliformis in semi-immune subjects.
These data support vertical transmission of B. bacilliformis.
Bartonella bacilliformis is an endemic pathogen from
Andean areas at 600–3,000 m above sea level (masl), and its
presentation has two phases. The first phase (acute phase) is
the so-called Oroya Fever, in which the pathogen invades the
red blood cells, causing severe anemia that may lead to death,
especially in the absence of antibiotic treatment. Indeed,
mortality rates had reportedly been as high as 90% in the pre-
antibiotic era.1,2 Oroya Fever mostly affects previously non-
exposed people.3 Thus, young children are especially affected
by this illness.3,4 In the second phase of the illness, which may
occur weeks to months after the acute phase (but may be
present in the absence of previously described acute phase
symptoms), the bacteria cause an abnormal proliferation of
endothelial cells, producing the so-called Peruvian wart.3,5
Additionally, the presence of healthy carriers, which may act
as a natural bacterial reservoir, has also been described.6
Natural transmission is mediated by a sandfly (different
members of the Lutzomyia genera) bite, but vertical and
post-transfusion transmissions have also been proposed as
possible routes of infection.7–10
In this report, a neonatal case of Oroya Fever from a non-
endemic coastal area of Peru is presented, and the possible
routes of transmission are discussed.
A 22-day-old male child was attended at the Hospital
Regional Eleanor Guzman Barron (HREGB; Nuevo
Chimbote, Peru) after 2 days of evolution of irritability and
breathing difficulty, jaundice, fever, and gastrointestinal
bleeding as reported by the mother. The child presented a
fever of 38.4°C, and biochemical analysis showed hyperbilir-
ubinemia (total bilirubin: 45.8 mg/dL; conjugate bilirubin:
13 mg/dL), creatinine levels of 1.7 mg/dL, and an erythrocyte
count of 12% with hemoglobin levels of 4 g/dL. Despite no
reports of B. bacilliformis in the area of the child’s origin, the
thin blood smear showed the presence of coccoid (90%) and
bacillar (10%) forms, leading to the diagnosis of Oroya Fever.
During hospitalization, severe red blood cell hemolysis and
digestive hemorrhage made a blood transfusion from the
mother necessary because of the lack of a blood bank.
Seven days after hospital admission, the child presented
worsening clinical evolution, including hepatosplenomegaly
and renal insufficiency, leading to his transfer to the Intensive
Care Unit of the Instituto Nacional de Salud del Nin˜o (INSN;
Lima, Peru), in which an additional pericardic effusion was
observed on cardiac echography. After admission to the INSN,
the initial diagnosis of Oroya Fever was confirmed by direct
blood polymerase chain reaction (PCR) (Figure 1) as previ-
ously described and posterior bacterial culture in 5% blood agar
plates incubated at 28°C in 5% CO2.
11,12 The microorganisms
were further identified as B. bacilliformis by amplification and
sequence of the 16s ribosomal RNA (rRNA) gene both directly
from blood samples and from growing microorganisms.12
After 10 days in the Intensive Care Unit, the child was
transferred to the Infectious Diseases Department, in which
concomitant pneumonia was also diagnosed.
During the stay in the INSN, the child was treated with
ciprofloxacin, ceftazidime, ampicillin, and vancomycin follow-
ing the schedule and dosages presented in Table 1; however,
during the previous stay in the HREGB, no data regarding
the precise therapeutic schedule were recorded. The child
received four additional packed red cells transfusions of
50 mL each, leading to a rise in hematocrit and hemoglobin
levels from 25% and 8 g/dL (day 14 after first attendance) to
48% and 11 g/dL (day 43 after first hospitalization), respec-
tively. After successful treatment, the neonate was discharged
from the INSN 44 days after the first hospitalization.
In this case, several severe complications were observed,
including pericarditis effusion and digestive hemorrhage as
well as pneumonia. These complications have been previously
described as relevant complications of severe Oroya Fever,
especially in children.13
A questionnaire given to the mother revealed her origin
as Huaraz, an endemic area of Carrion’s disease. Interest-
ingly, during the third trimester of pregnancy, the mother
presented a febrile syndrome, which was documented as a
urinary tract infection and treated with an unspecified anti-
biotic plus paracetamol. In the questionnaire, the mother
reported the presence of a wart, which was visually compati-
ble with endothelium proliferation of B. bacilliformis, but no
additional analyses or molecular determinations were made.
These data strongly suggest that, in this case, vertical transmis-
sion of Carrion’s disease took place, especially considering the
history of the mother, including a personal relationship with
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an endemic area, a gestational episode of fever, and the pres-
ence of a wart, in addition to the fact that the illness incuba-
tion time varies from 7 days to several months. Thus, possible
external infection can probably be ruled out.13
Three other methods of transmission should also be consid-
ered: natural (sandfly bite), transfusion, or breastfeeding.
Nonetheless, although infection transmitted by transfusion
could be ruled out in this case, because transfusion was done
after the diagnosis of the disease in the neonate, a sandfly bite
or breastfeeding transmission could not be ruled out. How-
ever, we need to note that this transfusion with maternal
blood resulted in an increase in the neonate bacterial burden,
playing a role in the aggravation of the clinical presentation,
which led to the child’s transfer to the INSN. Regarding the
transmission of Bartonella by breastfeeding, to the best of our
knowledge, it has not been described to date, but in the
absence of specific data, this possibility should be considered.
With respect to a sandfly bite as the cause of the episode
presented, this is unlikely, because Nuevo Chimbote is on the
Peruvian coast, and the presence of these vectors has not been
reported in this area (Lutzomyia vectors are located in areas
higher than 600 masl). However, stable or unstable introduc-
tion of illness transmission vectors, which may result in the
development of vector-borne diseases, has been largely
described.14 Thus, possible sporadic introduction of Carrion’s
disease vector in the area cannot be discarded. Furthermore,
possible visits by relatives from Huaraz, who may act as invol-
untary vector carriers, should also be considered.
Infection by B. bacilliformis during pregnancy has often
been related to serious maternal or fetal complications,
including miscarriage, fetal death, or pre-term birth among
others.15 Mother-to-child transmission was first proposed by
Tomas de Salazar in 1858,9 and it was also reported by both
Malpartida7 and Colareta8 in the mid-1930s. Nonetheless, a
bibliographic search showed very little data on the vertical
transmission of B. bacilliformis, being mainly limited to spo-
radic cases showing or suggesting this route of transmission.
Tuya and others16 reported the case of a 19-day-old child
presenting Oroya Fever with 30% parasitemia, in which the
mother also presented a positive thin blood smear. Tarazona
and others13 reported a pre-term child with a mother present-
ing verrucous lesions, in which blood samples from the child
collected at 90 minutes after birth resulted in a positive
Bartonella culture.8 Regarding other Bartonella spp., to our
knowledge, only perinatal transmission of B. vinsonii ssp.
berkhoffii and B. henselae has been reported,17 which strongly
suggests vertical transmission. Additionally, it is of note that
vertical transmission of members of the Bartonella genus has
been observed in naturally infected rodents.18
This quasiabsence of data regarding the vertical transmis-
sion of B. bacilliformismight be because of the lack of reports
in article format; also, it could be because the population at
risk lives in remote rural areas, in which health facilities have
many limitations, including the lack of diagnostic tools other
than microscopy, which is strongly expertise-dependent.
Social attitudes and practices may also result in delays or
non-attendance to health centers during pregnancy or after
childbirth. All of these factors may lead to an underestimation
or misdiagnosis of mother-to-child B. bacilliformis transmis-
sions.19 However, early adequate antibiotic treatment of preg-
nant women with Bartonella infection is effective to avoid or
limit both maternal illness complications and fetal/newborn
T
a
bl
e
1
A
n
ti
b
io
ti
c
sc
h
e
d
u
le
A
A
H
R
E
G
B
*
IN
S
N
In
te
n
si
v
e
C
a
re
U
n
it
In
fe
ct
io
u
s
D
is
e
a
se
s
D
e
p
a
rt
m
e
n
t
1
†
2
3
4
5
6
7
8
9
1
0
1
1
1
2
1
3
1
4
1
5
1
6
1
7
1
8
1
9
2
0
2
1
2
2
2
3
2
4
2
5
2
6
2
7
2
8
2
9
3
0
3
1
3
2
3
3
3
4
3
5
3
6
3
7
3
8
3
9
4
0
4
1
4
2
4
3
4
4
C
IP
3
5
m
g
/1
2
h
o
u
rs
C
A
Z
1
7
0
m
g
/8
h
o
u
rs
1
8
0
m
g
/8
h
o
u
rs
A
M
P
1
6
0
m
g
/6
h
o
u
rs
V
A
N
4
0
m
g
/6
h
o
u
rs
A
A
=
a
n
ti
b
a
ct
e
ri
a
l
a
g
e
n
t;
A
M
P
=
a
m
p
ic
il
li
n
;
C
IP
=
ci
p
ro
fl
o
x
a
ci
n
;
C
A
Z
=
ce
ft
a
zi
d
im
e
;
V
A
N
=
v
a
n
co
m
y
ci
n
.
*
N
o
d
a
ta
a
b
o
u
t
a
n
ti
b
io
ti
c
tr
e
a
tm
e
n
t
h
a
v
e
b
e
e
n
re
co
v
e
re
d
fr
o
m
re
co
rd
s
o
f
th
e
H
R
E
G
B
.
†
L
e
n
g
th
o
f
h
o
sp
it
a
l
st
a
y
in
d
a
y
s.
NEONATAL B. BACILLIFORMIS INFECTION 127
involvement,13 and it may, therefore, obviate or diminish
vertical transmission.
In summary, these data suggest the vertical transmission of
B. bacilliformis, reinforcing the need for early detection and
treatment of infected pregnant women.
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Figure 1. Direct blood PCR detection of B. bacilliformis. CN =
negative control; EC1 = positive control; EC125 = amplification of
DNA extraction from neonatal blood;WM =molecular weight marker.
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